news Archives - Page 36 of 100 - Journal for Clinical Studies

Current Edition

Europe

CarThera obtains ANSM approval to launch its Phase I-II clinical trial for the SonoCloud-9 device in the treatment of recurrent glioblastoma

Paris, France, January 15, 2019 - CarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today ann...

17 January 2019 Europe | news | Regional News

Continue Reading →

Europe

Align Clinical CRO Publishes New Operational Data Exchange Standard for Life Sciences Industry Input

Industry group’s first technology standard to make it easier for sponsors and CROs to share information during clinical trials. BARCELONA, Spain — 15 January 2019 — ...

17 January 2019 Europe | news | Regional News | Uncategorized

Continue Reading →

news

Pfizer initiates phase 2b/3 clinical trial for PF-06651600, an oral JAK3 inhibitor, for the treatment of patients with moderate to severe alopecia areata

Pfizer Inc. (NYSE: PFE) announced the initiation of a Phase 2b/3 clinical trial for its oral JAK3 inhibitor, PF-06651600, for the treatment of patients with moderate ...

10 January 2019 news | North America | Regional News

Continue Reading →

news

Lynparza meets primary endpoint in Phase III SOLO-3 trial for the treatment of relapsed BRCA-mutated advanced ovarian cancer

AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., US (Merck: known as MSD outside the US and Canada) announced positive results from the randomised, open-label...

10 January 2019 news | North America

Continue Reading →

news

Phase 3 Trial of Rova T as Second-line Therapy for Advanced Small-Cell Lung Cancer Halted

AbbVie , a research-based global biopharmaceutical company, announced the decision to stop enrollment for the TAHOE trial, a Phase 3 study evaluating Rovalpituzumab ...

10 January 2019 news | North America | Regional News

Continue Reading →

Europe

Nanobiotix and MD Anderson Cancer Center announce a large-scale, comprehensive clinical collaboration on NBTXR3

Collaboration will initially support nine new phase I/II clinical trials with Nanobiotix’s first-in-class agent NBTXR3 for use in treating six cancer types - head ...

10 January 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

Clinical Trial Launches to Develop Breath Test for Multiple Cancers

Cancer Research UK recruits first patients in trial to improve the early detection and diagnosis of different cancer types Study will use Owlstone Medical’s Brea...

10 January 2019 Europe | news | Regional News

Continue Reading →

Europe

North Estonia Medical Centre has joined the network of hospitals on Clinerion’s Patient Network Explorer platform.

North Estonia Medical Centre (NEMC) consists of seven clinics and 32 specialist centers, and is the most important caregiver in the capital of Estonia, Tallinn, as we...

10 January 2019 Europe | news | Regional News

Continue Reading →

news

AbbVie and J&J dominate clinical trial development in psoriatic arthritis, says GlobalData

AbbVie and Johnson & Johnson (J&J) are responsible for 47 of the 121 industry sponsored clinical trials in the psoriatic arthritis space, according to GlobalD...

10 January 2019 news | North America | Regional News

Continue Reading →

news

PCI Pharma Services Announces a more than $20 Million Expansion of Biotech Technologies Including Advanced Injectable Delivery Forms

Philadelphia, USA – January 07, 2019 Leading global biopharmaceutical services provider PCI Pharma Services (PCI) has announced a momentous investment in support of b...

7 January 2019 news | North America | Regional News

Continue Reading →